中华皮肤科杂志 ›› 2012, Vol. 45 ›› Issue (3): 195-198.

• 论著 • 上一篇    下一篇

绞股蓝皂苷对光损伤小鼠皮肤中核因子κ B、p38 MAPK的影响

邓丹琪1,李扬1,王医林1,袁李梅2,刘流3   

  1. 1. 昆明医学院第二附属医院
    2. 昆明医学院第二附属医院皮肤病性病/风湿免疫科
    3. 昆明医学院第一附属医院头颈颌面外科
  • 收稿日期:2011-05-06 修回日期:2011-12-13 出版日期:2012-03-15 发布日期:2012-02-29
  • 通讯作者: 刘流 E-mail:liuliu3939@126.com
  • 基金资助:

    云南省卫生厅科研基金

Effects of gypenosides on nuclear factor κB and p38 mitogen activated protein kinase signaling pathways in photodamaged skin of mice

  • Received:2011-05-06 Revised:2011-12-13 Online:2012-03-15 Published:2012-02-29

摘要:

目的 观察绞股蓝皂甙(Gyuostemma penataptiyllam ,GP)对光损伤Balb/C小鼠皮肤中核转录因子kappa-B、p38丝裂原活化蛋白激酶(p38MAPK)的影响,进一步探讨绞股蓝皂甙抗皮肤光损伤的可能机制。方法 采用7次隔日UVB照射Balb/C小鼠建立皮肤光损伤的动物模型,应用Western Blot法检测小鼠皮肤中核转录因子kappa-B (NF-?B)I?B蛋白(kappaB抑制蛋白)、IKK蛋白(?B抑制蛋白激酶)及p38MAPK、磷酸化p38MAPK(pp38)的表达。结果 1.空白对照组小鼠表皮中I?B、IKK蛋白未见表达;2.UVB照射组的小鼠表皮中I?B蛋白水平与其它组相比明显减低,而IKK蛋白与其它组相比表达较高;3.应用1.5%绞股蓝皂甙霜组I?B蛋白表达明显高于UVB照射组; IKK蛋白表达明显低于UVB照射组,与阳性对照VitE组小鼠皮肤中I?B蛋白、IKK蛋白的表达结果相似。4. 各组p38MAPK表达量没有明显变化;5. UVB照射组的小鼠表皮中pp38蛋白表达高于其他组;6. 1.5%绞股蓝皂甙霜组pp38蛋白表达明显低于UVB照射组,阳性对照VitE组小鼠皮肤中pp38蛋白的表达和绞股蓝皂甙霜组相似。结论 UVB辐射促使NF-?B 活化,激活磷酸化p38MAPK; 1.5%绞股蓝皂甙霜能抑制NF-?B通路及p38MAPK的激活,可能是其抗炎、抗光损伤的作用机理之一。

关键词: p38丝裂原活化蛋白激酶

Abstract:

Objective To observe the effects of gypenosides (GP) on nuclear factorκB (NF-κB) and p38 mitogen activated protein kinase (p38MAPK) signaling pathways in photodamaged skin of mice, and to explore the mechanisms underlying the protective effects of GP against photodamage. Methods Eighty Balb/C female mice were randomly divided into 8 groups: blank control group receiving no treatment, ultraviolet B (UVB) model group receiving UVB irradiation for 60 seconds, GP groupⅠreceiving topical GP treatment followed by UVB irradiation, GP group Ⅱreceiving UVB irradiation followed by topical GP treatment, VitE groupⅠreceiving topical VitE treatment followed by UVB irradiation, VitE groupⅡreceiving UVB irradiation followed by topical VitE treatment, matrix groupⅠreceiving topical matrix treatment followed by UVB irradiation, matrix groupⅡreceiving UVB irradiation followed by topical matrix treatment. UVB irradiation lasted 60 seconds at one time, and was given once every other day for 7 times to establish a skin model of photodamage. The interval between irradiation and topical treatment was 30 minutes in all the groups except the control group and UVB model group. After the last treatment, mice were sacrificed. Western blot was performed to measure the protein expressions of inhibitor of NF-κB(I-κB), inhibitor of NF-κB kinase (IKK), p38MAPK as well as phosphorylated p38MAPK (pp38) in skin tissue from the mice. Results No expressions of I-κB or IKK were observed in the blank control group. The expression level of I-κB was 0.40 ± 0.07 in UVB model group, significantly lower than that in GP group I (1.63 ± 0.85, P < 0.05) and GP group II (0.90 ± 0.40, P < 0.05), whereas the level of IKK protein was higher in UVB model group than in the GP group I and II (2.01 ± 1.75 vs. 0.23 ± 0.12 and 0.45 ± 0.29, both P < 0.05). No significant difference was observed in the expression of I-κB or IKK proteins between the GP group I, II , VitE group I and II or in the expression of p38MAPK between the 8 groups. The phosphorylated p38MAPK expression in UVB model group was significantly higher than that in GP group I and II (0.835 ± 0.049 vs. 0.425 ± 0.054 and 0.571 ± 0.090, both P < 0.05), but similar to that in VitE groups. Conclusions UVB can activate NF-κB and phosphorylated p38MAPK signaling pathways; GP 1.5% cream can inhibit UVB-induced activation of NF-?Objective To observe the effects of gypenosides (GP) on nuclear factorκB (NF-κB) and p38 mitogen activated protein kinase (p38MAPK) signaling pathways in photodamaged skin of mice, and to explore the mechanisms underlying the protective effects of GP against photodamage. Methods Eighty Balb/C female mice were randomly divided into 8 groups: blank control group receiving no treatment, ultraviolet B (UVB) model group receiving UVB irradiation for 60 seconds, GP groupⅠreceiving topical GP treatment followed by UVB irradiation, GP group Ⅱreceiving UVB irradiation followed by topical GP treatment, VitE groupⅠreceiving topical VitE treatment followed by UVB irradiation, VitE groupⅡreceiving UVB irradiation followed by topical VitE treatment, matrix groupⅠreceiving topical matrix treatment followed by UVB irradiation, matrix groupⅡreceiving UVB irradiation followed by topical matrix treatment. UVB irradiation lasted 60 seconds at one time, and was given once every other day for 7 times to establish a skin model of photodamage. The interval between irradiation and topical treatment was 30 minutes in all the groups except the control group and UVB model group. After the last treatment, mice were sacrificed. Western blot was performed to measure the protein expressions of inhibitor of NF-κB(I-κB), inhibitor of NF-κB kinase (IKK), p38MAPK as well as phosphorylated p38MAPK (pp38) in skin tissue from the mice. Results No expressions of I-κB or IKK were observed in the blank control group. The expression level of I-κB was 0.40 ± 0.07 in UVB model group, significantly lower than that in GP group I (1.63 ± 0.85, P < 0.05) and GP group II (0.90 ± 0.40, P < 0.05), whereas the level of IKK protein was higher in UVB model group than in the GP group I and II (2.01 ± 1.75 vs. 0.23 ± 0.12 and 0.45 ± 0.29, both P < 0.05). No significant difference was observed in the expression of I-κB or IKK proteins between the GP group I, II , VitE group I and II or in the expression of p38MAPK between the 8 groups. The phosphorylated p38MAPK expression in UVB model group was significantly higher than that in GP group I and II (0.835 ± 0.049 vs. 0.425 ± 0.054 and 0.571 ± 0.090, both P < 0.05), but similar to that in VitE groups. Conclusions UVB can activate NF-κB and phosphorylated p38MAPK signaling pathways; GP 1.5% cream can inhibit UVB-induced activation of NF-κB and p38MAPK pathways, which may be one of the mechanisms underlying its protective effects against inflammation and photodamage

Key words: p38 mitogen activated protein kinases

中图分类号: 

  • R758.14